As Venture Advisor, Rick supports the overall business commercialization efforts including development of business strategies, capitalization and milestone planning, competitor analysis, preparation of investor presentations and facilitating access to the Angel and Venture Capital markets. He specializes in areas with emphasis in Life Sciences.
In coordination with OCAST, Rick directs the Oklahoma SBIR Collaborative Resource project (OSCR) which provides support to small, innovative Oklahoma companies or researchers in need of staged capital for their projects. OSCR seeks to improve both the quality and the quantity of SBIR/STTR applications, which in turn will increase the total number of federal grants or contracts being awarded to Oklahoma entities.
Rick has held management positions involving Quality Systems and Regulatory Affairs responsibilities for Pharmaceutical Formulations, Inc. and DPT Laboratories, Inc. During this time, he drafted and submitted Abbreviated New Drug Applications for OTC products, maintained company intellectual property, as well as hired and managed an Analytical Development team responsible for the transfer, qualification and training of customer methods in compliance with FDA processes.
Rick earned his BS in Chemistry from the University of Central Oklahoma which allowed him to pursue his interests in Pharmaceutical Manufacturing and Quality. He also holds a Masters Degree from the University of Sciences in Philadelphia in Pharmaceutical Business, where he studied the pharmaceutical business model.